Gain Therapeutics Stock Price History
GANX Stock | USD 1.74 0.01 0.58% |
If you're considering investing in Gain Stock, it is important to understand the factors that can impact its price. As of today, the current price of Gain Therapeutics stands at 1.74, as last reported on the 27th of November, with the highest price reaching 1.86 and the lowest price hitting 1.71 during the day. Gain Therapeutics is very risky given 3 months investment horizon. Gain Therapeutics holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.0% are justified by taking the suggested risk. Use Gain Therapeutics Downside Deviation of 7.2, market risk adjusted performance of 0.6069, and Risk Adjusted Performance of 0.0754 to evaluate company specific risk that cannot be diversified away.
At this time, Gain Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to 1,436 in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 11.9 M in 2024. . At this time, Gain Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 3.55 in 2024, whereas Price To Sales Ratio is likely to drop 732.51 in 2024. Gain Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Gain |
Sharpe Ratio = 0.1394
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | GANX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.18 actual daily | 63 63% of assets are less volatile |
Expected Return
1.0 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Gain Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gain Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.1506 | Enterprise Value Ebitda (1.55) | Price Sales 925.9162 | Shares Float 24.2 M | Wall Street Target Price 7.4 |
Gain Therapeutics Stock Price History Chart
There are several ways to analyze Gain Stock price data. The simplest method is using a basic Gain candlestick price chart, which shows Gain Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 16, 2024 | 2.92 |
Lowest Price | September 4, 2024 | 1.04 |
Gain Therapeutics November 27, 2024 Stock Price Synopsis
Various analyses of Gain Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Gain Stock. It can be used to describe the percentage change in the price of Gain Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Gain Stock.Gain Therapeutics Price Rate Of Daily Change | 1.01 | |
Gain Therapeutics Price Action Indicator | (0.04) | |
Gain Therapeutics Accumulation Distribution | 20,846 | |
Gain Therapeutics Price Daily Balance Of Power | 0.07 |
Gain Therapeutics November 27, 2024 Stock Price Analysis
Gain Stock Price History Data
The price series of Gain Therapeutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 1.88 with a coefficient of variation of 26.96. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.88. The median price for the last 90 days is 1.82.Open | High | Low | Close | Volume | ||
11/27/2024 | 1.73 | 1.86 | 1.71 | 1.74 | 258,491 | |
11/26/2024 | 1.83 | 1.85 | 1.72 | 1.73 | 76,783 | |
11/25/2024 | 1.79 | 1.90 | 1.76 | 1.82 | 239,450 | |
11/22/2024 | 1.60 | 1.78 | 1.56 | 1.72 | 205,127 | |
11/21/2024 | 1.65 | 1.75 | 1.56 | 1.62 | 194,626 | |
11/20/2024 | 1.68 | 1.75 | 1.61 | 1.66 | 141,791 | |
11/19/2024 | 1.69 | 1.77 | 1.63 | 1.72 | 190,383 | |
11/18/2024 | 1.87 | 2.00 | 1.63 | 1.69 | 407,466 | |
11/15/2024 | 1.66 | 1.90 | 1.66 | 1.85 | 450,962 | |
11/14/2024 | 2.03 | 2.03 | 1.64 | 1.75 | 438,485 | |
11/13/2024 | 2.10 | 2.19 | 1.94 | 2.03 | 223,740 | |
11/12/2024 | 2.14 | 2.19 | 2.02 | 2.08 | 192,367 | |
11/11/2024 | 2.20 | 2.25 | 2.05 | 2.17 | 197,859 | |
11/08/2024 | 2.23 | 2.28 | 2.10 | 2.22 | 156,005 | |
11/07/2024 | 2.29 | 2.34 | 2.19 | 2.23 | 165,108 | |
11/06/2024 | 2.24 | 2.31 | 2.20 | 2.27 | 224,176 | |
11/05/2024 | 2.06 | 2.30 | 2.02 | 2.22 | 191,973 | |
11/04/2024 | 2.29 | 2.39 | 2.07 | 2.07 | 398,533 | |
11/01/2024 | 2.53 | 2.55 | 2.30 | 2.32 | 351,319 | |
10/31/2024 | 2.15 | 2.56 | 2.15 | 2.50 | 478,781 | |
10/30/2024 | 2.55 | 2.58 | 2.12 | 2.18 | 500,180 | |
10/29/2024 | 2.63 | 2.67 | 2.27 | 2.57 | 359,437 | |
10/28/2024 | 2.68 | 2.75 | 2.60 | 2.65 | 140,503 | |
10/25/2024 | 2.66 | 2.74 | 2.57 | 2.65 | 259,072 | |
10/24/2024 | 2.75 | 2.75 | 2.60 | 2.68 | 239,689 | |
10/23/2024 | 2.80 | 2.80 | 2.55 | 2.68 | 219,514 | |
10/22/2024 | 2.80 | 2.81 | 2.53 | 2.69 | 230,134 | |
10/21/2024 | 2.71 | 2.82 | 2.63 | 2.79 | 218,233 | |
10/18/2024 | 2.80 | 2.90 | 2.45 | 2.70 | 424,766 | |
10/17/2024 | 2.99 | 3.19 | 2.70 | 2.77 | 775,978 | |
10/16/2024 | 2.42 | 3.14 | 2.35 | 2.92 | 1,199,685 | |
10/15/2024 | 2.35 | 2.52 | 2.17 | 2.40 | 683,821 | |
10/14/2024 | 2.06 | 2.36 | 2.05 | 2.35 | 583,457 | |
10/11/2024 | 1.99 | 2.08 | 1.94 | 2.07 | 195,201 | |
10/10/2024 | 2.05 | 2.05 | 1.91 | 1.97 | 177,363 | |
10/09/2024 | 2.08 | 2.08 | 1.90 | 2.04 | 235,029 | |
10/08/2024 | 2.16 | 2.16 | 1.87 | 1.98 | 295,480 | |
10/07/2024 | 1.90 | 2.14 | 1.83 | 2.13 | 598,162 | |
10/04/2024 | 1.73 | 1.84 | 1.71 | 1.82 | 304,509 | |
10/03/2024 | 1.69 | 1.77 | 1.58 | 1.72 | 286,450 | |
10/02/2024 | 1.66 | 1.67 | 1.58 | 1.64 | 144,729 | |
10/01/2024 | 1.81 | 1.81 | 1.54 | 1.64 | 399,891 | |
09/30/2024 | 1.99 | 1.99 | 1.63 | 1.78 | 609,138 | |
09/27/2024 | 1.85 | 2.00 | 1.82 | 1.99 | 621,680 | |
09/26/2024 | 1.85 | 1.85 | 1.54 | 1.85 | 404,064 | |
09/25/2024 | 1.68 | 1.85 | 1.63 | 1.78 | 599,231 | |
09/24/2024 | 1.55 | 1.64 | 1.54 | 1.62 | 241,763 | |
09/23/2024 | 1.47 | 1.78 | 1.45 | 1.55 | 310,055 | |
09/20/2024 | 1.52 | 1.55 | 1.43 | 1.43 | 384,592 | |
09/19/2024 | 1.50 | 1.55 | 1.46 | 1.50 | 174,603 | |
09/18/2024 | 1.50 | 1.50 | 1.36 | 1.48 | 237,741 | |
09/17/2024 | 1.49 | 1.50 | 1.42 | 1.50 | 201,261 | |
09/16/2024 | 1.45 | 1.54 | 1.41 | 1.48 | 167,430 | |
09/13/2024 | 1.44 | 1.53 | 1.40 | 1.47 | 123,836 | |
09/12/2024 | 1.48 | 1.50 | 1.37 | 1.47 | 143,959 | |
09/11/2024 | 1.33 | 1.56 | 1.33 | 1.49 | 647,165 | |
09/10/2024 | 1.16 | 1.43 | 1.13 | 1.27 | 418,885 | |
09/09/2024 | 1.04 | 1.18 | 1.00 | 1.16 | 294,816 | |
09/06/2024 | 1.07 | 1.10 | 1.00 | 1.05 | 237,826 | |
09/05/2024 | 1.04 | 1.11 | 1.02 | 1.09 | 105,209 | |
09/04/2024 | 1.04 | 1.06 | 1.01 | 1.04 | 142,765 |
About Gain Therapeutics Stock history
Gain Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Gain is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Gain Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Gain Therapeutics stock prices may prove useful in developing a viable investing in Gain Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 13 M | 11.9 M | |
Net Loss | -15.8 M | -15 M |
Gain Therapeutics Quarterly Net Working Capital |
|
Gain Therapeutics Stock Technical Analysis
Gain Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Gain Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Gain Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Gain Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Gain to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0754 | |||
Jensen Alpha | 0.5151 | |||
Total Risk Alpha | (0.54) | |||
Sortino Ratio | 0.0729 | |||
Treynor Ratio | 0.5969 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Gain Stock Analysis
When running Gain Therapeutics' price analysis, check to measure Gain Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gain Therapeutics is operating at the current time. Most of Gain Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gain Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gain Therapeutics' price. Additionally, you may evaluate how the addition of Gain Therapeutics to your portfolios can decrease your overall portfolio volatility.